Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels
about
The use of animal models in diabetes research.Glucose regulates free cytosolic Zn²⁺ concentration, Slc39 (ZiP), and metallothionein gene expression in primary pancreatic islet β-cellsDopamine modulates insulin release and is involved in the survival of rat pancreatic beta cellsNifedipine in Congenital Hyperinsulinism - A Case Report.Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric G proteins.Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanismsA mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1.Congenital hyperinsulinism: current trends in diagnosis and therapy.Investigation of morin-induced insulin secretion in cultured pancreatic cells.In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.Aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor-1{beta} plays a critical role in maintaining glucose-stimulated anaplerosis and insulin release from pancreatic {beta}-cells.Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9.The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia.Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: A mini review.Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?
P2860
Q34255921-3B2B465F-444F-4843-9181-94B4010B1C3DQ35110905-78752A4D-1E0F-4138-885F-713D143BC699Q35464909-DFA1AEE0-9E43-4208-8A81-12E7E3A78524Q36038850-8D8F0E53-1A67-488B-8871-3A55C8B249AFQ36041923-F37B09B5-D17F-4C1E-B124-328B778D2EE4Q36093354-EAD83FDA-8B58-494E-AC30-493B425AFF53Q37251122-C23223D2-9B01-49EE-8F47-6B2DDA5B3507Q37941900-4A2D3E5D-409E-42DA-A0FA-FBBC8F984E5EQ38697506-2FC093BF-EFE5-44DC-B56C-AD8595EC6C88Q38732653-418E7C99-FD37-46DD-85F3-42DF71E5F46BQ39634434-513FD2C8-B16A-4A26-A776-F50F72EA4DA9Q41786052-1541E3B1-D779-4C41-BF0F-582DC5EFD8F4Q42082788-F91CC6B9-F73C-4D2C-BDDF-C44219ADF203Q48176468-5C37965A-43C2-4F67-AC9E-9B8D0C8CE604Q51127204-CBDB7632-E115-4512-9BCB-03CF357CF450Q53150911-FD918BEB-CAE1-423D-9D99-B60F48EF5B8C
P2860
Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacological stimulation an ...... king ATP-sensitive K+ channels
@ast
Pharmacological stimulation an ...... king ATP-sensitive K+ channels
@en
type
label
Pharmacological stimulation an ...... king ATP-sensitive K+ channels
@ast
Pharmacological stimulation an ...... king ATP-sensitive K+ channels
@en
prefLabel
Pharmacological stimulation an ...... king ATP-sensitive K+ channels
@ast
Pharmacological stimulation an ...... king ATP-sensitive K+ channels
@en
P2860
P1476
Pharmacological stimulation an ...... king ATP-sensitive K+ channels
@en
P2093
J C Henquin
P2860
P304
P356
10.1111/J.1476-5381.2009.00588.X
P407
P577
2010-01-28T00:00:00Z